Online:
Visits:
Stories:
Profile image
By Voice of Reason
Contributor profile | More stories
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Google’s “PROJECT IMMORTALITY” is the Latest in Google’s Twisted Research & Development

Sunday, March 29, 2015 2:40
% of readers think this story is Fact. Add your two cents.

(Before It's News)

“YOU ARE TRAVELING THROUGH ANOTHER DIMENSION, A DIMENSION NOT ONLY OF SIGHT AND SOUND BUT OF MIND. A JOURNEY INTO THE A WONDROUS LAND OF IMAGINATION. 

NEXT STOP, THE TWILIGHT ZONE!” - Twilight Zone Season 3

If this is the first post of mine that you’re reading involving the Department of Defense agency known as DARPA, then I HIGHLY suggest you read some of the links at the bottom. ANY time you see the words DARPA, HAARP, FEMA, or D.H.S., I would suggest reading whatever it is that has those words contained within. If you happen to see something that mentions ALL of them together, RUN!

The reason I mention DARPA in an article about Google’s “Project Immortality,” is because of who heads the Research & Development Department for Google these days: None other than the former Head of DARPA, Regina Dugan. For those who don’t know, DARPA is the agency within the Department of Defense that handles most our country’s black ops, or black budget projects. For example, two weeks ago I posted an article on HAARP titled: PHYSICIST DR. FRAN DE AQUINO SAYS HAARP CAN MANIPULATE TIME. Anyone who takes the time to watch some of those videos and look into HAARP, will soon learn that our government is into some REALLY crazy stuff that’s even too far fetched to pass as believable in most science fiction movies. 

WHAT DOES ANY OF THIS HAVE TO DO WITH IMMORTALITY?

In my not so humble opinion, it’s more the WHO that plays a part in this story than the WHAT. Not that long ago, CONSPIRACY THEORISTS WERE VINDICATED, AND IT WAS CONFIRMED THAT HAARP IS RESPONSIBLE FOR WEATHER MODIFICATION. If “conspiracy theorists” were right about that, one might wonder if they are also correct about HAARP BEING TESTED BY DARPA FOR MIND CONTROL EXPERIMENTS? It’s not like our government has never done experiments on Americans in the area of mind control. The post titled: OPERATION PAPERCLIP ought to sufficiently churn your stomach when you learn what the U.S. government was doing 70 years ago, let alone what they must be capable of today… my God!

So what is DARPA, and why does DARPA’S former chief going to GOOGLE matter?

DARPA – Defense Advanced Research Projects Agency is:

… an independent agency of the United States Department of Defense (DOD) that focuses on developing cutting edge technology to ensure that the United States remains ahead of its enemies. The organization has contributed a number of technologies to the United States military and the world in general, including the groundwork for the Internet. Many of the workings of this agency are kept concealed from the public, in the interests of keeping its technology under wraps so that it is not exploited by other nations.

The agency was founded in 1958, after the Soviet Union launched Sputnik, the first satellite. The United States government realized that it needed a small, mobile, independent research organization if it wanted to meet threats to American security quickly and decisively. Initially, the agency was called the Advanced Research Projects Agency (ARPA), and it focused on aerospace research and threats to national security such as nuclear testing by other nations.

By 1972, the organization’s mission had evolved, and the government had added “Defense” to the title, turning it into DARPA. It began to focus on looking forward into the future, working on highly experimental technology in small, focused groups. This system continues to be used by the agency today, with it focusing on goal-oriented projects that are intended to improve America’s military and defense systems.

DARPA has a number of divisions that are divided into smaller teams focusing on a variety of issues. Information technology is an important part of its research, for example, as are tools that are used on the battlefield, such as drones, armored vehicles, and communications jamming equipment. The agency also focuses on the threat of weapons of mass destruction, and it counters emerging threats to American security and information awareness. It has many small but very dedicated groups of active researchers and experiments, who may work together for up to five years developing a project and delivering a prototype.

Because DARPA technology is used to protect national security and make the United States more effective militarily, it is largely classified. It is also extremely advanced, since the organization focuses on technological superiority. Periodically, information about agency projects does reach the public, but the details are usually deliberately obscured. Civilians, for example, might be aware that it is working on a cloaking device for camouflaging soldiers, but they will not be aware of the mechanics of the system.

Now that you know what DARPA is, imagine DARPA’S former chief in charge of one of the biggest Research and Development budgets on earth. Still not impressed? Keep in mind the close ties Google and the NSA were PROVEN to have during the whole NSA scandal. If you REALLY want to learn something try the following two pieces written by: “INSURGE INTELLIGENCE, a new crowd-funded investigative journalism project, breaks the exclusive story of how the United States intelligence community funded, nurtured and incubated Google as part of a drive to dominate the world through control of information. Seed-funded by the NSA and CIA, Google was merely the first among a plethora of private sector start-ups co-opted by US intelligence to retain ‘information superiority.’”

WHAT DOES ALL THIS HAVE TO DO WITH “PROJECT IMMORTALITY?”

RIGHT?

I am bringing all this to your attention before the “Project Immortality” articles below because I am of the VERY strong belief that anyone who has been as far down the rabbit hole as Regina Dugan has, and anyone who’s had access to THAT level of cutting edge technology, technology which some say is roughly 80 years past anything the private sector has in existence today, is not quite “right” in the head for lack of a better way to put it. After all, this is the SAME WOMAN WHO IS PUSHING FOR ALL AMERICANS TO BE MICRO CHIPPED WITHIN THREE YEARS!

See the following:

IMGS7699-X2-640x427

Former DARPA head Regina Dugan now leads special projects for the Google-owned Motorola, and she claims to be very excited about wearable computers.By that she doesn’t necessarily mean something so pedestrianly futuristic as Google Glass or a smartwatch. Dugan means electronic tattoos and pills.

“We got to do a lot of epic shit when I was at DARPA,” Dugan said onstage at D11. But the stuff she is working on at Motorola is pretty cool (and totally creepy!) too:

  • An electronic tattoo that can be used to authenticate a user instead of some flimsy password. It’s made by a company called MC10 that Motorola is partnering with, and Dugan is wearing it on her own arm.
  • Another option in a similar vein: Vitamin authentication. Dugan shows a pill that can be ingested and then battery-powered with stomach acid to produce an 18-bit internal signal. After that, the swallower’s whole body becomes a password.

IMGS7774-X2-380x253

“This isn’t stuff that is going to ship anytime soon. But it is a sign of the new boldness inside Motorola,” explained Dugan’s boss, Motorola head Dennis Woodside. And Dugan and Woodside claimed that all this is entirely optional; Google is not going to be force-feeding us pills.

“If you want to ensure failure in your innovation, try removing the risks,” Dugan said. “Boredom is the enemy of innovation.”

FULL D11 CONFERENCE COVERAGE

One person who read this article had the following to say:

Anyone else find it very frightening the ex-DARPA head is now working on Goggle’s secret projects, especially after it’s came out that Google has been in bed with the NSA & handing over user info for government spying programs? The stuff that’s going on screams 1984 crossed with an Isaac Asimov sci-fi, combining the world of thought crimes & always watching big bro with future tech that can read your thoughts & instantly doll out appropriate punishment via implanted control chips inserted at birth. Or real “Smart Water” with active nano-bots programmed to do various insidious tasks. Or even the now mundane idea of the “mark of the beast”, but with a high tech twist via the interactive tattoo that Dr. D is sporting in the above photo, necessary for transactions in daily life from buying & selling goods & services to starting your car & opening the door to your house.

Welcome to the future, jump in, the water’s fine!

Read the article at the L.A. Times Here

I THINK YOU PROBABLY SEE WHY THIS SHOULD CAUSE CONCERN!

Join my Twitter feed | Like my Facebook page

Page

The Verge reports: Yesterday, Google CEO Larry Page announced what is perhaps his company’s most audacious project: a life science startup called Calico that will pursue solutions for aging and its associated diseases. As Time Magazine put it, Calico hopes to cure death. In many ways, this new venture seemed to come out of left field. But Page actually has a long history with the search for immortality.

Page has long been a fan of Ray Kurzweil, the legendary inventor and author who popularized the concept of the Singularity, a theoretical tipping point where technology becomes so advanced it begins to radically alter the fabric of our existence. In the documentary Transcendent Man, Kurzweil openly talks about his ambition to achieve eternal life, even speculating that it might be possible to bring his dead father back from the grave in the process.

In 2008 Google became one of the corporate backers of the Singularity University, of which Kurzweil is a co-founder. According to a report in the New York Times, Page and Google provided more than $250,000 in donations to help found the university and several of Google’s early employees have personally donated $100,000 or more. In December of last year, Google hired Kurzweil.

“LARRY PAGE IS PLANNING FOR THE SINGULARITY”

The topic of defeating death has become central to the discourse around the Singularity. Last year’s Singularity Summit featured speakers like Laura Deming, who told a rapt crowd that, “There is one fact that never fails to infuriate me. Every day 150,000 die of a disease that we ignore.” Deming, a scientific prodigy who at just 18 years old has dedicated her life to ending aging, went on to say that “if we succeed, we will have turned the most awful paradigm that we know on its head. The inevitability of death.”

[Audio/Video below cannot be seen in Newsletter - have to go to Blog]

There is another, more practical reason why Google is increasingly interested in life sciences. The study of life science is increasingly about genetics, and genetics is becoming a question of computing power and machine learning. While the amount of venture capital funding flowing into the life sciences has dropped precipitously since 2008, Google Ventures has been one of the few Silicon Valley investors expanding its stake in this area.

“Digital insights are becoming increasingly important in the life sciences, because genetics is a data-driven practice, giving us a real place to add value,” says Dr. Krishna Yeshwant, a general partner with Google Ventures. “There is a lot of opportunity because a lot of the traditional players have been scared off and there is less money available even for the top-tier companies that are great bets.”

“I’M INTERESTED IN IDEAS THAT SOUND A LITTLE BIT CRAZY”

In his post announcing Calico, Page specifically thanked Bill Maris, the managing partner at Google Ventures, saying he helped bring the project to life and get Art Levinson involved. Levinson is the former CEO and current chairman of Genentech, and another one of the corporate founders behind the Singularity University. As Maris told the Wall Street Journal last year, “I’m interested in the ideas that sound a little crazy, such as radical life extension, curing cancer, being able to create a simulation of the human brain and map every neuron.”

Yesterday’s announcement about the launch of Calico was met with surprise and excitement. But as Google pushes further in the direction of radical life extension, it will likely incite a heated debate. Skeptics point out that without aging humanity may face a crisis of overpopulation, or at least an enormous imbalance between productive members of the workforce and older citizens eager for retirement. Anti-aging work also highlights the question of how best to dedicate resources to the acute illnesses that can take young lives, or the universal problem of aging.

Join my Twitter feed | Like my Facebook page

“One of the things I thought was amazing is that if you solve cancer, you’d add about three years to people’s average life expectancy,” Page said in his interview with Time. “We think of solving cancer as this huge thing that’ll totally change the world. But when you really take a step back and look at it, yeah, there are many, many tragic cases of cancer, and it’s very, very sad, but in the aggregate, it’s not as big an advance as you might think.”

GOOGLE VENTURES & THE SEARCH FOR IMMORTALITY

[Audio/Video below cannot be seen in Newsletter - have to go to Blog]

 

“If you ask me today, is it possible to live to be 500? The answer is yes,” Bill Maris says one January afternoon in Mountain View, California. The president and managing partner of Google Ventures just turned 40, but he looks more like a 19-year-old college kid at midterm. He’s wearing sneakers and a gray denim shirt over a T-shirt; it looks like he hasn’t shaved in a few days.

Behind him, sun is streaming through a large wall of windows. Beyond is the leafy expanse of the main Google campus. Inside his office, there’s not much that gives any indication of the work Maris does here, Bloomberg Markets will report in its April 2015 issue. The room is sparse—clean white walls, a few chairs, a table. On this day, his desk has no papers, no notepads or Post-its, not even a computer.

This story appears in the April 2015 issue of Bloomberg Markets.

Cover

Join my Twitter feed | Like my Facebook page

Here’s where you really figure out who Bill Maris is: on his bookshelf. There’s a fat text called Molecular Biotechnology: Principles and Applications of Recombinant DNA. There’s a well-read copy of Biotechnology: Applying the Genetic Revolution. And a collection of illustrations by Fritz Kahn, a German physician who was among the first to depict the human body as a machine. Wedged among these is a book that particularly stands out to anyone interested in living to 500. The Singularity Is Near: When Humans Transcend Biology, published in 2005, is the seminal work by futurist Ray Kurzweil. He famously predicted that in 2045, humankind will have its Terminator moment: The rise of computers will outpace our ability to control them. To keep up, we will radically transform our biology via nanobots and other machines that will enhance our anatomy and our DNA, changing everything about how we live and die.

“It will liberate us from our own limitations,” says Maris, who studied neuroscience at Middlebury College and once worked in a biomedical lab at Duke University. Kurzweil is a friend. Google hired him to help Maris and other Googlers understand a world in which machines surpass human biology. This might be a terrifying, dystopian future to some. To Maris, it’s business.

This is where he hopes to find, and fund, the next generation of companies that will change the world, or possibly save it. “We actually have the tools in the life sciences to achieve anything that you have the audacity to envision,” he says. “I just hope to live long enough not to die.”

***

Maris is an unusual guy with an unusual job. Seven years ago, Sergey Brin and Larry Page, the founders of Google, tapped him to start a venture capital fund, putting him smack between those tech titans and the sea of ambitious entrepreneurs trying to be just like them. At the time, he was a young entrepreneur himself, with limited investing experience and no clout in Silicon Valley. He’d sold his Vermont-based Web-hosting company and was working at a nonprofit, developing technology for cataract blindness in India. This made him exactly the kind of outsider Google was looking for. “Bill was ready to come at this from an entirely new perspective,” says David Drummond, who, as Google’s chief legal officer and senior vice president of corporate development, oversees Google Ventures as well as the company’s other investment vehicles.

Marris

Bill Maris in the Google Ventures offices. His firm’s sole limited partner is the world’s largest search company.

Ian Allen/Bloomberg Markets

Google Ventures has close to $2 billion in assets under management, with stakes in more than 280 startups. Each year, Google gives Maris $300 million in new capital, and this year he’ll have an extra $125 million to invest in a new European fund. That puts Google Ventures on a financial par with Silicon Valley’s biggest venture firms, which typically put to work $300 million to $500 million a year. According to data compiled by CB Insights, a research firm that tracks venture capital activity, Google Ventures was the fourth-most-active venture firm in the U.S. last year, participating in 87 deals.

Join my Twitter feed | Like my Facebook page

A company with $66 billion in annual revenue isn’t doing this for the money. What Google needs is entrepreneurs. “It needs to know where the puck is heading,” says Robert Peck, an analyst at the investment bank SunTrust Robinson Humphrey, who published a report in February examining Google’s outside investment units, including Google Ventures. “Look at what happened to BlackBerry when it missed the advent of smartphones. And Yahoo! missed Facebook.”

Google puts huge resources into looking for what’s coming next. It spends millions on projects like Google X, the internal lab that developed Google Glass and is working on driverless cars. In January, the company made a $900 million investment in Elon Musk’s SpaceX. In 2014, it started Google Capital to invest in later-stage technology companies. Maris’s views on the intersection of technology and medicine fit in well here: Google has spent hundreds of millions of dollars backing a research center, called Calico, to study how to reverse aging, and Google X is working on a pill that would insert nanoparticles into our bloodstream to detect disease and cancer mutations.

Pie

Maris has a peculiar position in the Googlesphere. He’s a part of it, but also free from it. Google Ventures is set up differently than most other in-house corporate venture funds—Intel Capital, Verizon Ventures, and the like. The firm makes its investments independent of its parent’s corporate strategy. It can back any company it wants, whether or not it fits with Google’s plans. The fund also can sell its stakes to whomever it wants, including Google competitors. Facebook and Yahoo have bought startups funded by Google Ventures.

With Google’s money and clout behind him, Maris has a huge amount of freedom. He can, and does, go after Silicon Valley’s most-sought-after startups. Uber, Nest, and Cloudera are among the firm’s big wins. Maris doesn’t intend to stop pursuing these kinds of deals. But he has other ambitions, too. “There are plenty of people, including us, that want to invest in consumer Internet, but we can do more than that,” he says. He now has 36 percent of the fund’s assets invested in life sciences, up from 6 percent in 2013.

“There are a lot of billionaires in Silicon Valley, but in the end, we are all heading to the same place,” Maris says. “If given the choice between making a lot of money or finding a way to make people live longer, what do you choose?”

***

Maris is standing at the front of Joshua Tree, Google Ventures’ large conference room. Each room at headquarters is named after a national park. “OK, we have a lot to get through today,” he tells his staff. The group meets here biweekly to talk about prospects and strategy.

Maris has a team of 70, most of whom are in the room this day or patched in by phone or video. The group includes the fund’s 17 investing partners, who are in charge of finding startups. Among the investing partners are Joe Kraus, co-founder of Excite; Rich Miner, co-founder of Android; and David Krane, employee No. 84 at Google.

Join my Twitter feed | Like my Facebook page

The mood in the room is casual. Some staffers sit cross-legged on the floor; others curl up on soft felt couches. There are a lot of jokes. One partner starts his presentation with a slide entitled “Secret Project”—which most people in the room already know about—and concludes it with a doctored-up photo of Maris’s head superimposed on the body of someone playing tambourine. It’s a jab at the boss, who married the singer-songwriter Tristan Prettyman last August and recently went on tour with her. Everyone laughs. Maris smiles, but immediately he’s back to business. “Time is the one thing I can’t get back and can’t give back to you,” he says, turning to an agenda on the screen behind him.

“I know you’re all aware of the conference happening this week,” Maris says. An hour away in San Francisco, JPMorgan Chase is hosting its annual health-care confab, nicknamed the Super Bowl of Health Care. Thousands of pharmaceutical executives and investors have gathered for what has become a huge part of the industry’s dealmaking. Most of Google Ventures’ life sciences startups are attending. One, Foundation Medicine, which uses genetic data to create diagnostic oncology tools, is generating huge buzz this year. In January, Roche Holding announced plans to take a majority stake in the company, in a transaction valued at $1 billion. The stock more than doubled the next day. Google Ventures has a 4 percent stake in the company.

For Maris, Foundation Medicine represents the beginning of a revolution. “The analogy I use is this,” he says, holding up his iPhone 6. “Even five years ago, this would have been unimaginable. Twenty years ago, you wouldn’t have been able to talk to anyone on this.”

Article

A group from Slack goes through a design sprint with the Google Ventures design team. In the orange pants is Jake Knapp, who runs the sprints.

Cody Pickens/Bloomberg Markets

When Google Ventures invested in Foundation in 2011, the company’s promise was mostly theoretical. The world was still waiting for the breakthroughs that have seemed inevitable ever since scientists first mapped the human genome in 2003. Foundation’s team included eminent geneticists, including Eric Lander, one of the leaders of the Human Genome Project. Still, the company had no viable commercial product.

Technology has made huge strides since then, allowing Foundation to create products like its Interactive Cancer Explorer, which is a kind of Google for oncologists, allowing them to do research and devise treatments for their patients. “We had a lot to learn from the experts in Silicon Valley,” says Foundation’s CEO, Dr. Michael Pellini, who sought out Google Ventures as an investor for help with designing his company’s technology. “Think about Google search. We never think about all the algorithms that go behind what we see on the screen. They were able to do the same for us with genetic information.”

“Twenty years ago, without genomics, you could only treat cancer with a poison,” Maris says. “That’s really different from, ‘We can cure your cancer by reverse-engineering a stem cell.’ You can now legitimately invest in a company that could cure cancer.”

Identifying promising life sciences companies isn’t like hunting around Silicon Valley for coders with a cool app. Biotech companies are built around complicated science. They require millions of dollars in investments, partnerships with big pharma companies, and lengthy clinical trials. To help with his hunt, Maris has brought in scientists as partners. One, Dr. Krishna Yeshwant, a Harvard- and Stanford-trained doctor, still works in a clinic twice a week in Boston, where he is based. Last year, he led the firm’s biggest bet in life sciences, an investment in Flatiron Health, which is building a cloud platform to analyze cancer data.

This is just the beginning. “In 20 years,” Maris says, “chemo will seem so primitive it will be like using a telegraph.”

***

At the age of 22, just out of college, Maris met the friend who would lead him to Google. It was 1997: Yahoo was search, AOL was e-mail, Google was called BackRub. Maris was in New York, working at Investor AB, a Swedish investing firm. He didn’t care for Wall Street, but he did like the smart Yale grad sitting next to him. She told him about a company that was going to change the world. “I remember telling him about this new search engine my sister was working on, and he said, ‘Oh, Yahoo is good enough,’” recalls Anne Wojcicki, who would become the wife of Sergey Brin. Her sister Susan, one of Google’s earliest employees, is now CEO of YouTube. Anne Wojcicki went on to co-found 23andMe, a genetics testing company that is part of Google Ventures’ portfolio.

Join my Twitter feed | Like my Facebook page

Maris quit Investor AB after six months and went to Burlington, Vermont, to start a Web-hosting company. He was so green that he read Netscape and the World Wide Web for Dummies. He funded his company, Burlee, with his credit cards and by convincing the operators of the Lake Champlain ferry to invest. Maris sold Burlee to a company that became Web.com for an undisclosed sum in 2002. It wasn’t Google-level money, but it was enough for him to live on in Vermont with no job.

He would have stayed there except that his old friend, Wojcicki, kept calling him West. Maris started visiting her and Brin, staying at their home in California. He increasingly became drawn into their sphere. “He and Larry and Sergey would be at dinner and start talking about, I don’t know, flying cars,” recalls Wojcicki.

In 2008, Google’s chiefs tapped Maris to start a venture fund, an idea they’d been kicking around for a while. They gave him a desk at Google and instructions to figure out how he would invest Google’s money. In an only-at-Google twist, his neighbor was Kevin Systrom, who was working on a photo app called Burbn, later Instagram. (“Everyone I sit next to ends up becoming a billionaire,’’ Maris jokes.)

Coming Back

Maris spent six months researching venture capital around Silicon Valley. He traveled up and down Sand Hill Road, home to many of the Valley’s most prestigious VC firms, asking top investors for advice. At first, he had a hard time getting anyone to take him seriously. During one meeting, a VC started laughing at his idea for Google Ventures.

Maris was told his fund would never work: VCs wouldn’t want Google looking over their shoulders. “There were some in the venture world who weren’t particularly welcoming to Bill or Google Ventures,” recalls John Doerr, a legendary partner at Kleiner Perkins Caufield & Byers, one of the most important first-generation California VC firms. Doerr, who sits on Google’s corporate board, advised Maris on setting up the venture fund.

Around Silicon Valley, corporate venture funds have a bad reputation. “There is an inherent paradox to the notion of corporate venture,” says Bill Gurley, a general partner at the VC firm Benchmark Capital. The conflict is, do the fund’s loyalties lie with the startup or with the parent? Just about every independent venture capitalist in tech has stories of being burned by corporate funds. Either the company uses its venture investments to gather intelligence and ends up competing with the companies it funds or company management loses interest at some point and pulls out.

Entrepreneurs were skeptical, too. “I told him, this is never going to work,” says Joe Kraus, who, in addition to co-founding Excite, co-founded a wiki software company called JotSpot, which was sold to Google. Maris asked him early on to join as a partner in Google Ventures. “From the entrepreneur’s perspective, the idea of tying myself to Google would have been scary.” Kraus says. “The fear would be, if you raised money from Google, would Apple hate you?”

Entrepreneurs who can get comfortable with Google Ventures gain access to resources no amount of money can buy.

To win over other VCs and entrepreneurs, Maris and his bosses at Google established the terms under which the fund still operates. Google has no access to details about the startups’ strategy or technology. That way, entrepreneurs can pitch without worrying about their ideas being stolen. “We had to convince entrepreneurs they could work with us,” says David Drummond.

Those who can get comfortable with Google Ventures gain access to resources no amount of money can buy. The firm can, and does, introduce its startup founders to anyone at Google—experts on rankings on Google search, for example, or user experience designers or Android mobile-app builders. One startup was offered 1 million hours of core processing time on the Google cloud for free.

A big edge for Google Ventures is its design team. Maris drew top tech talent out of Google and made them partners in the fund. One worked on Gmail; another helped redesign YouTube. They form a sort of SWAT team for startups. In what’s known as a design sprint, they can troubleshoot whatever is ailing a startup—a flailing app, slow Web traffic, an uninspiring home page. (See “On the Clock,” above.)

Join my Twitter feed | Like my Facebook page

“We didn’t need the money,” says Ryan Caldbeck, co-founder of the crowdfunding startup CircleUp. He picked Google Ventures as one of his backers in part to gain access to its design talent. Twitter co-founder Ev Williams used the design team for his new publishing platform, Medium. Stewart Butterfield, co-founder of Flickr, used the team for his new startup, Slack.

Still, navigating the line between startups and Google can get complicated. Last year, Google wanted to buy Nest, whose signature product is a WiFi-connected, learning home thermostat. Google Ventures recused itself from the negotiations, allowing the other VC firms invested in Nest to broker a price of $3.2 billion. (It was the fourth-largest venture exit of 2014.) In February, Bloomberg reported that Google was planning a ride-sharing app that would be a direct competitor to Uber. Google Ventures has had a stake in Uber since 2013. If Google and Uber go to war, Maris will be right in the middle of it.

“Google Ventures has a direct financial incentive to ensure the companies we invest in succeed,” Maris said in an e-mail responding to questions about potential conflicts. “Our investment decisions are made independent of Google’s product road map.” He and the other partners are paid carried interest based on the performance of portfolio companies. In theory, if Google’s car app kills Uber, Google Ventures loses money.

***

One evening in San Francisco, a group of young scientists and doctors are sitting down to dinner. “I remember when Max was living with me and I opened up my fridge and saw this stuff he put in there. I was thinking, Is this safe?” muses Blake Byers, a 30-year-old with a Ph.D. in bioengineering from Stanford and a partner at Google Ventures. He casts a sideways glance at Max Hodak, a 25-year-old Duke biomedical engineering grad sitting next to him. Three years ago, Hodak started working in Byers’s garage to build a robot-enabled laboratory. Once he stored chemicals in Byers’s freezer. (“Blake gets a little carried away with that story,’’ says Hodak. “There was never any danger.”)

Hodak now runs Transcriptic, a company that builds and operates robot-run labs in shipping container–sized boxes. It packs them with enough computing power to run multiple experiments from anywhere in the world. Theoretically, a scientist in Monrovia, Liberia, with access to a laptop or a mobile phone could use a Transcriptic lab to test strains of Ebola. Byers, who is the son of Brook Byers of Kleiner Perkins, has helped Hodak raise $12.5 million from Google Ventures and others.

“We are just on the verge of what science and technology can do,’’ says David Shaywitz, chief medical officer of DNAnexus, who’s seated across from Byers and Hodak. His company, also backed by Google Ventures, is building a global bank of genomic information using cloud computing.

Listening to the scientists gathered around the table, it’s hard not to get caught up in the world they see coming. In this vision of our future, science will be able to fix the damage that the sun or smoking or too much wine inflicts on our DNA. Alzheimer’s, Parkinson’s, and other scourges of aging will be repaired at the molecular level and eradicated. In the minds of this next generation of entrepreneurs, the possibilities are bizarre and hopeful and endless. We probably won’t live forever, but we could live much longer, and better.

These are the bets Google Ventures is hoping will ultimately be its biggest wins. “We aren’t trying to gain a few yards,” Maris says. “We are trying to win the game. And part of it is that it is better to live than to die.”

Read the article at Bloomberg here:

Join my Twitter feed | Like my Facebook page

 

THE VOICE OF REASON

darpa

FOR SOME VERY INTERESTING ARTICLES ON DARPA, HAARP, CHIPPING, ETC.:

nsa-spying

UNCONSTITUTIONAL ACTS PERFORMED BY THE NSA:

 

BE SURE TO CHECK OUT THE GIFT SHOP!

 

 

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.